Associations of Serum testosterone and sex hormone-binding globulin with incident Arrhythmias in men from UK Biobank.

Arrhythmias Atrial fibrillation/flutter Sex hormone-binding globulin Testosterone

Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
04 Sep 2023
Historique:
received: 12 04 2023
revised: 29 08 2023
accepted: 31 08 2023
medline: 4 9 2023
pubmed: 4 9 2023
entrez: 4 9 2023
Statut: aheadofprint

Résumé

Sex hormones have been identified as cardiovascular risk factors, while the relationship between sex hormones and the risk of arrhythmias in men has not yet been well studied in the prospective cohort study. To analyze associations of serum testosterone, sex hormone-binding globulin (SHBG) concentrations and calculated free testosterone (cFT) with arrhythmias in men. Sex hormones were measured at baseline from UK Biobank. Main outcomes were incidence of atrial fibrillation/flutter (AF), ventricular arrhythmia (VA), bradyarrhythmia (BA). Of 173 498 men (aged 37 to 73 years, followed for 11 years), 11 368 had incident AF, 1 646 had incident VA, and 4 788 had incident BA. Compared with the third quartiles, the lowest category of serum testosterone was associated with increased risks of AF (HR 1.06, 95% CI 1.00-1.12) and BA (HR 1.11, 95% CI 1.02-1.20) after multivariable adjustment, but no VA. Likewise, similar associations were found between cFT values and AF and BA events. Furthermore, higher levels of cFT were associated with increased risks of AF (HR 1.07, 95% CI 1.02-1.13) and VA (HR 1.18, 95% CI 1.01-1.37). Higher SHBG concentrations were associated with increased risks of AF (HR 1.44, 95% CI 1.34-1.54), VA (HR 1.27, 95% CI 1.07-1.52), and BA (HR 1.17, 95% CI 1.05-1.29). Lower levels of testosterone and cFT were associated with increased risk of AF and BA. Higher cFT levels were associated with increased risk of AF and VA. Higher SHBG levels were associated with increased risk of AF, VA, and BA.

Identifiants

pubmed: 37665960
pii: 7259838
doi: 10.1210/clinem/dgad526
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Bingyan Xu (B)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Wei Mo (W)

Department of Endocrinology & Metabolism, Guangdong Second Traditional Chinese Medicine Hospital, Guangzhou, China.

Xiangliang Tan (X)

Department of Endocrinology and metabolism, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.

Peizhen Zhang (P)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Junlin Huang (J)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Chensihan Huang (C)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Dan Guo (D)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Xueyun Wei (X)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Yating Liu (Y)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Xuzhen Lei (X)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Weijuan Dou (W)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Jiayang Lin (J)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Deying Liu (D)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Linjie Yang (L)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Yan Huang (Y)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Huijie Zhang (H)

Department of Endocrinology and metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangzhou, China.

Yunfei Liao (Y)

Department of Endocrinology and metabolism, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.

Classifications MeSH